Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Scopus

Scopus profile and journal metrics

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022
First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
Original full research article

Patterns of antimicrobial consumption and bacterial resistance in intensive care units: a pilot study from Palestine

Published
2021-11-27
Pages
167 - 176
Full text

Keywords

  • Palestine
  • Antimicrobial resistance
  • Antimicrobial consumption
  • ICU
  • DDD/100 bed days

Abstract

Background: Antimicrobial resistance has become a worldwide issue as the number of multidrug-resistant (MDR) bacteria has risen considerably. The irrational use of antibiotics contributes significantly to this issue. Methods: A prospective study was conducted over three months at a teaching hospital in surgical and medical intensive care units (SICU, MICU) in Palestine. Antimicrobial consumption data were recorded and analyzed using the antimi-crobial consumption tool. Microorganisms and their resistance patterns were obtained from the microbiology laboratory. Results: One hundred patients with a median age of 50 years were included in this study (65% males). More than half of the patients were admitted to the MICU (55 patients). Vancomycin, piperacillin-tazobactam, and fluconazole were the most highly consumed antimicrobials, in terms of defined daily dose(DDD)/100-bed day, in the SICU (37, 31, and 27, respectively). On the other hand, meropenem, vancomycin, and levofloxacin were the most commonly consumed antimicrobials in the MICU (49, 35, and 26, respectively). The most frequent organisms were Coagulase-negative Staphylococci spe-cies, Escherichia coli, and Enterococcus faecalis (15%, 12%, and 9%, respectively). There were two Vancomycin-resistant Enterococcus faecium (VRE) cases in each ICU. Methicillin-resistant Staphylococcus aureus (MRSA) was common in the MICUs (five isolates). In both ICUs, A. baumannii, Escherichia coli, P. aeruginosa, and Klebsiella pneumonia showed ex-tensive resistance to the tested antibiotics. The isolated Enterococcus faecium from both ICUs were highly resistant to the commonly used antibiotics. Conclusion: This study revealed high consumption of the most potent antibiotics and the prevalence of multidrug-resistant or-ganisms (MDRO) in the tested ICUs. This highlights the need to adhere to the antibiotic stew-ardship policy to use antibiotics appropriately and reduce the presence of these MDROs.

Article history

Received
2021-09-08
Accepted
2021-11-27
بحث أصيل كامل

Patterns of antimicrobial consumption and bacterial resistance in intensive care units: a pilot study from Palestine

Published
2021-11-27
الصفحات
167 - 176
البحث كاملا

الكلمات الإفتتاحية

  • Palestine
  • Antimicrobial resistance
  • Antimicrobial consumption
  • ICU
  • DDD/100 bed days

الملخص

Background: Antimicrobial resistance has become a worldwide issue as the number of multidrug-resistant (MDR) bacteria has risen considerably. The irrational use of antibiotics contributes significantly to this issue. Methods: A prospective study was conducted over three months at a teaching hospital in surgical and medical intensive care units (SICU, MICU) in Palestine. Antimicrobial consumption data were recorded and analyzed using the antimi-crobial consumption tool. Microorganisms and their resistance patterns were obtained from the microbiology laboratory. Results: One hundred patients with a median age of 50 years were included in this study (65% males). More than half of the patients were admitted to the MICU (55 patients). Vancomycin, piperacillin-tazobactam, and fluconazole were the most highly consumed antimicrobials, in terms of defined daily dose(DDD)/100-bed day, in the SICU (37, 31, and 27, respectively). On the other hand, meropenem, vancomycin, and levofloxacin were the most commonly consumed antimicrobials in the MICU (49, 35, and 26, respectively). The most frequent organisms were Coagulase-negative Staphylococci spe-cies, Escherichia coli, and Enterococcus faecalis (15%, 12%, and 9%, respectively). There were two Vancomycin-resistant Enterococcus faecium (VRE) cases in each ICU. Methicillin-resistant Staphylococcus aureus (MRSA) was common in the MICUs (five isolates). In both ICUs, A. baumannii, Escherichia coli, P. aeruginosa, and Klebsiella pneumonia showed ex-tensive resistance to the tested antibiotics. The isolated Enterococcus faecium from both ICUs were highly resistant to the commonly used antibiotics. Conclusion: This study revealed high consumption of the most potent antibiotics and the prevalence of multidrug-resistant or-ganisms (MDRO) in the tested ICUs. This highlights the need to adhere to the antibiotic stew-ardship policy to use antibiotics appropriately and reduce the presence of these MDROs.

Article history

تاريخ التسليم
2021-09-08
تاريخ القبول
2021-11-27